- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01837537
Respiration Rate V2.0 in a Hospital Setting
Evaluation of Respiration Rate Parameters in a Hospital Population Using a Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Volunteer subjects from a hospital setting (see specific inclusion/exclusion criteria) over the age of 18, male and female, who provide written informed consent prior to the procedure, and are without any contact skin allergies to adhesives found in standard pulse oximetry sensors. A cross section of demographics - cardiovascular, respiratory, and metabolic type cases should be considered for a broad distribution of medical and surgical patients.
The study consists of measuring parameters related to respiration in hospitalized volunteers by means of the Bedside Respiratory Patient Monitoring System with RR V2.0 (Nightingale). The production-equivalent Nightingale device and multiparameter reference devices will be attached to the subject via sensors, nasal cannulas and ECG leads and the information from all devices will be captured continuously for up to 40 minutes to allow for at least 30 minutes of artifact free data 30 minutes.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Ohio
-
Columbus, Ohio, Forenede Stater, 43210
- The Ohio State University Wexner Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Male or female.
- 18 years or older.
- A patient at the study site on a General Care Floor or General Surgery Care Floor.
- Subject is willing and able to provide written consent.
Exclusion Criteria:
- Subject is younger than 18.
- Subject has severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors.
- Subject has an abnormality that may prevent proper application of the device.
- Subject is in atrial fibrillation.
- Subject has a documented history of frequent premature ventricular contractions (PVCs), defined as greater than 3 in 30 seconds or greater than 6 in 60 seconds.
- Subject has an implanted pacemaker.
- Subject is unwilling or unable to sign informed consent.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
---|
ingen behandling
ingen behandling, prospektiv observation
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Mean Error (ME) +/- 1 Breath Per Minute, RR Sensor
Tidsramme: up to 40 minutes of continuous monitoring
|
The software calculates respiration rate values via Adult Respiratory Sensor with a mean error of +/- 1 breath per minute relative to a capnography based reference.
The Mean Error value estimates the mean difference in simultaneous estimates of respiration rate (the Respiration Rate calculated from the sensor and the Respiration Rate calculated from capnography).
|
up to 40 minutes of continuous monitoring
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Mean Error (ME) +/- 1 Breath Per Minute, Max-N Sensor
Tidsramme: up to 40 minutes of continuous monitoring
|
The software calculates respiration rate values via the Max-N Sensor with a mean error of +/- 1 breath per minute relative to a capnography based reference.
The Mean Error value estimates the mean difference in simultaneous estimates of respiration rate (the Respiration Rate calculated from the sensor and the Respiration Rate calculated from capnography).
The error value estimates the mean difference in simultaneous estimates of respiration rate (the Respiration Rate calculated from the Max-N sensor minus the Respiration Rate calculated from capnography.
|
up to 40 minutes of continuous monitoring
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- COVMOPR0399
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Åndedrætsfrekvens
-
Suzhou Genhouse Bio Co., Ltd.Aktiv, ikke rekrutterendeAvancerede solide tumorer | Kirsten Rat SarkomKina
-
AmgenRekrutteringAvancerede solide tumorer | Kirsten Rat Sarcoma (KRAS) pG12C mutationForenede Stater, Italien, Taiwan, Spanien, Det Forenede Kongerige, Australien, Østrig, Tyskland, Belgien, Japan, Holland, Korea, Republikken, Canada
-
Hospices Civils de LyonAfsluttetAkut Respiratory Distress Syndrome (ARDS)Frankrig
-
Aqualung Therapeutics Corp.Ikke rekrutterer endnuAkut Respiratory Distress Syndrome (ARDS)
-
Unity Health TorontoRekrutteringAkut Respiratory Distress Syndrome (ARDS)Canada, Spanien, Italien, Brasilien
-
Hospices Civils de LyonAfsluttetAkut Respiratory Distress Syndrome (ARDS)Frankrig
-
European Society of Intensive Care MedicineAfsluttetModerat Akut Respiratory Distress SyndromeBelgien
-
Policlinico HospitalAfsluttetAkut Respiratory Distress Syndrome (ARDS)Italien
-
Gamaleya Research Institute of Epidemiology and...Ikke rekrutterer endnuAkut Respiratory Distress Syndrome (ARDS)
-
Centre Hospitalier Universitaire DijonRekrutteringFocal Acute Respiratory Distress SyndromeFrankrig